2-hydroxy-3-oxo-3,4-dihydroquinoxaline-6-sulfonyl chloride, 98%, 1g

[(3-methylphenyl)(phenyl)methyl]amine hydrochloride, 95.0%, 5g

Óxido de lutecio en polvo 99,9% 2 g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(7-methyl-1H-indol-3-yl)propanoic acid, 98+%, 250mg

4-{5-[(2S)-2-pyrrolidinyl]-1,2,4-oxadiazol-3-yl}pyridine dihydrochloride, 95.0%, 10g

2,2,2-Trifluoro-N-(3-morpholin-4-yl-propyl)-acetamide, 95.0%, 25g

3-(3-Chloro-4-methylphenyl)-2-methyl-1-propene, 97.0%, 1g

N-(2-Hydroxyethyl)nitotinamide, 95.0%, 1g

2-Chloro-6-methylphenol, 97.0%, 10g

3-Phenyl-p-anisidine hydrochloride, 95.0%, 1g

(3-Ethynylphenyl)boronic acid, 95.0%, 1g

Paclobutrazol>98.0%(T)5g

Fmoc-Dap-OH, 95.0%, 5g